EGFR and breast carcinoma: More importantly, since ERBB3 belongs to the ErbB family, there have been a large number of studies to explore the treatment mechanism and efficacy of ERBB3 targeting HER2-positive breast cancer, and our study complements the mechanism of the occurrence and development of HER2-positive breast cancer and provides possible effective markers and treatment ideas.